ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Neurology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,575Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 185

$1.2M Total Retail Price of All Prescriptions

Rank: 10 out of 185

734 Patients Receiving at Least One Drug in Part D
53%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 734 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 734 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 2,959 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$182 was the average price of a prescription from this provider, compared to $241 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
GABAPENTIN 450 247 1 1
LEVETIRACETAM 327 156 2 3
PHENYTOIN SODIUM EXTENDED 237 118 3 13
HYDROCODONE-ACETAMINOPHEN 236 51 S3 4 8
NAMENDA 219 191 5 5
DONEPEZIL HCL 207 205 6 4
TOPIRAMATE 171 42 7 6
LYRICA 167 60 8 12
LAMOTRIGINE 164 56 9 7
CARBAMAZEPINE 156 49 10 18
AMITRIPTYLINE HCL 146 30 R 11 21
CYMBALTA 142 67 12 11
PRIMIDONE 135 49 13 9
CARBIDOPA-LEVODOPA 130 84 14 2
BACLOFEN 129 29 15 10
VIMPAT 124 33 16 23
TRAMADOL HCL 110 51 17 24
DIVALPROEX SODIUM 101 23 18 27
DIVALPROEX SODIUM ER 100 17 19 14
ROPINIROLE HCL 91 47 20 17
SERTRALINE HCL 85 29 21 31
PLAVIX 83 71 22 50
METHADONE HCL 82 35 S2 23 75
CITALOPRAM HBR 78 41 24 19
ZONISAMIDE 75 0 25 25
RISPERIDONE 71 61 26 51
DILANTIN 69 37 27 16
CYCLOBENZAPRINE HCL 69 29 R 27 44
PRAMIPEXOLE DIHYDROCHLORIDE 65 38 29 15
CLOPIDOGREL 60 50 30 37
OXCARBAZEPINE 59 0 31 32
ZOLPIDEM TARTRATE 58 37 32 36
AMPYRA 55 0 33 78
AGGRENOX 54 51 34 38
VERAPAMIL ER 50 18 35 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.